Cerebrospinal ACE Levels in Diabetics Are Different Than in Non-Diabetics: A Pilot Study of Standard CSF-ACE Levels Using Mouse Monoclonal Antibodies Generated Against Human ACE

Update Item Information
Identifier 20050215_nanos_posters_041.pdf
Title Cerebrospinal ACE Levels in Diabetics Are Different Than in Non-Diabetics: A Pilot Study of Standard CSF-ACE Levels Using Mouse Monoclonal Antibodies Generated Against Human ACE
Creator Hadas Steibel-Kalish, MD; Arie Erman, MD, PhD, Yuval Kalish, PhD; Vadim Kolianov, MD; Eldad Melamed, MD
Affiliation Petah Tikva, Israel
Subject Neurosarcoidosis; ACE; Diabetes
Description Patients suspected for neurosarcoidosis may also be diabetic. Correct interpretation of CSF levels of ACE may aid in the future diagnosis of patients with diabetes and neurosarcoidosis, and thus ensure treatment with steroids for neurosarcoidosis will not be given to diabetics with falsely-elevated ACE levels.
Date 2005-02-15
Language eng
Format application/pdf
Type Text
Source 2005 North American Neuro-Ophthalmology Society Annual Meeting
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6pz8g8s
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181231
Reference URL https://collections.lib.utah.edu/ark:/87278/s6pz8g8s
Back to Search Results